Gender-Dependent Associations of Anxiety and Depression Symptoms With Eating Disorder Psychopathology in a Representative Population Sample

Background: Evidence shows that anxiety and depressive disorders play an important role in eating disorder behavior. However, given the epidemiology of eating disorders, there is a need to investigate potentially gender-specific connections.Method: This study tested the associations of anxiety and depression symptoms with eating disorder symptoms and behaviors and explored whether they differed between men and women. Within a population-representative survey (N = 2,510; ages 14–94), participants completed measures of depression symptoms (PHQ-2), anxiety symptoms (GAD-2), and eating disorder symptoms (EDE-Q8). We conducted linear regression analyses of the EDE-Q8 sum score and General Linear Models on the three behaviors overeating, binge eating, and compensatory behaviors (self-induced vomiting/use of laxatives/excessive exercising).Results: Depression and anxiety symptoms were related to more eating disorder symptoms in men and women (irrespective of BMI, age, and income). The association of depression and eating disorder symptoms was slightly stronger in women. Overeating was more common in men and in depressed individuals, whereas compensatory behaviors were more common among anxious individuals, especially anxious women.Conclusion: The study extends previous research by using gender-specific methods in a representative sample. It indicates similarities and differences between men and women regarding disordered eating on a population level.

Download Full-text

Anxiety and depression symptoms in women with and without binge eating disorder enrolled in weight loss programs

Trends in Psychiatry and Psychotherapy ◽

10.1590/s2237-60892012000200007 ◽

2012 ◽

Vol 34 (2) ◽

pp. 87-92 ◽

Cited By ~ 8

Author(s):

Simone Armentano Bittencourt ◽

Paola Lucena-Santos ◽

João Feliz Duarte Moraes ◽

Margareth da Silva Oliveira

Keyword(s):

Weight Loss ◽

Eating Disorder ◽

Binge Eating ◽

Binge Eating Disorder ◽

Structured Interview ◽

Anxiety Symptoms ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Weight Loss Programs ◽

Severity Of Depression

OBJECTIVES: 1) To investigate the association between binge eating scores, anxiety and depression symptoms, and body mass index (BMI), and 2) to assess the presence of differences in severity of anxiety symptoms, severity of depression symptoms, and BMI in women with and without binge eating disorder. METHOD: The sample comprised 113 women aged between 22 and 60 years (39.35±10.85) enrolled in weight loss programs in Porto Alegre, southern Brazil. The following instruments were used: structured interview, Brazilian Economic Classification Criteria, Beck Anxiety Inventory, Beck Depression Inventory, and Binge Eating Scale. Data were analyzed using descriptive and inferential statistics. RESULTS: A positive association was found between binge eating scores and the severity of anxiety symptoms (p < 0.001) and depression symptoms (p < 0.001). No significant association was observed between BMI and binge eating scores (p = 0.341). There were significant differences between women with and without binge eating disorder with regard to severity of anxiety symptoms (p < 0.001) and severity of depression symptoms (p < 0.001). Conversely, no significant differences were observed between the groups concerning BMI (p = 0.103). CONCLUSION: Our findings showed that binge eating is associated with symptoms of anxiety and depression, but not with BMI.

Download Full-text

Anxiety and depression in patients hospitalized in cardiology

European Journal of Preventive Cardiology ◽

10.1093/eurjpc/zwab061.386 ◽

2021 ◽

Vol 28 (Supplement_1) ◽

Author(s):

K Mzoughi ◽

I Zairi ◽

A Saadaoui ◽

I Ben Mrad ◽

S Kraiem

Keyword(s):

Hospital Stay ◽

Depressive Disorders ◽

Length Of Hospital Stay ◽

Anxiety Symptoms ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Active Smoking ◽

Cross Sectional ◽

Early Management ◽

Coronary Syndrome

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Anxio-depressive disorders represent one of the psychiatric manifestations most frequently observed in hospitalized patients. Different factors can be involved in the onset or worsening of these disorders. Purpose The aim of our study was to evaluate the prevalence of of anxiety and depression in hospitalized cardiology patients and to determine their predictors. Methods This was a cross-sectional and descriptive study with a prospective data collection that included 150 patients hospitalized in the cardiology department of Habib Thameur hospital between November and December 2016. Anxiety and depression were assessed using the Hospital Anxiety Depression questionnaire validated in Arabic. Results Patients mean age was 60 ± 11.2 years with a gender ratio of 2.7. Seventy-nine percent of the patients had a school education, 85.3% were married and 46% were active workers. Cardiovascular risk factors were dominated by arterial hypertension found in 56.7% of patients, followed by diabetes in 55.3%, dyslipidemia in 54.7% and active smoking in 43.3%. The most frequent reason for hospitalization was acute coronary syndrome, which was found in 52.7% of cases. The mean length of hospital stay was 13.7 ± 9.3 days. The prevalence of anxiety symptoms and depression symptoms was 55.3% and 40%, respectively. In multivariate analysis, age over 65 and active smoking were significantly associated with anxiety symptoms (OR = 0.345, 95% CI 0.150-0.790; p = 0.012 and OR = 0.44, 95% CI, respectively 0.194-0.90; p = 0.045). Independent factors significantly associated with depression symptoms in hospitalized cardiology patients were age greater than 65 years and a hospital stay of more than 7 days (OR = 0.171, respectively, 95% CI 0.067-0.438; p = 0.0001 and OR = 0.462, 95% CI 0.08-0.466; p = 0.001). Conclusion Given the high prevalence of anxiety and depression in patients hospitalized in cardiology, the systematic identification of the factors associated with these disorders would facilitate screening and ensure their early management.

Download Full-text

Anxiety and depression prevalence in digestive cancers: a systematic review and meta-analysis

BMJ Supportive & Palliative Care ◽

10.1136/bmjspcare-2021-003275 ◽

2021 ◽

pp. bmjspcare-2021-003275

Author(s):

Mohammad Zamani ◽

Shaghayegh Alizadeh-Tabari

Keyword(s):

Oesophageal Cancer ◽

Meta Analysis ◽

Anxiety Symptoms ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Hepatic Cancer ◽

Early Management ◽

Pooled Prevalence ◽

Digestive Cancers ◽

Gi Cancers

BackgroundCancers of the digestive system can be associated with disturbing and disabling symptoms, which can contribute to a negative psychological pressure on patients.AimTo investigate the reported prevalence of symptoms of anxiety and depression in patients with major digestive cancers, including oesophageal, gastric, colorectal, pancreatic or hepatic cancers.MethodsWe searched Embase, PubMed, Scopus and Web of Science for articles published from inception to December 2020. We included studies reporting the prevalence of anxiety or depression symptoms using validated questionnaires in adult patients (≥18 years).ResultsIn total, 51 eligible papers were finally included. Overall, the pooled prevalence of anxiety symptoms was 20.4% (95% CI 17% to 23.8%). The estimate in patients with gastrointestinal (GI) cancers was 19.1% and in patients with hepatic cancer was 29.1%. Among GI cancers, the highest pooled prevalence of anxiety symptoms related to oesophageal cancer (20.6%), while the lowest pooled prevalence pertained to gastric cancer (18.7%). Regarding depression symptoms, the overall pooled prevalence was 30.2% (95% CI 24.3% to 36.1%). The estimate in patients with GI cancers was 31% and in patients with hepatic cancer was 21.5%. Among GI cancers, the highest pooled prevalence of depression symptoms related to oesophageal cancer (45.2%), while the lowest pooled prevalence pertained to colorectal cancer (22.9%).ConclusionA considerable prevalence of anxiety and depression symptoms is observed in patients with digestive cancers. Screening and preventive measures with early management of these psychological problems by clinicians could possibly improve outcomes for these patients.PROSPERO registration numberCRD42020210079.

Download Full-text

Association Between Paranoia And Anorexia Nervosa In Adolescents: What Factors Are Involved?

10.21203/rs.2.24625/v1 ◽

2020 ◽

Author(s):

Gennaro Catone ◽

Filomena Salerno ◽

Giulia Muzzo ◽

Valentina Lanzara ◽

Antonella Gritti

Keyword(s):

Eating Disorders ◽

Body Image ◽

Anorexia Nervosa ◽

Eating Disorder ◽

Social Anxiety ◽

Associated Factors ◽

Anxiety Symptoms ◽

Pediatric Care ◽

Eating Disorder Symptoms ◽

Body Image Concerns

Abstract Background: psychiatric comorbidities are of particular interest in Eating disorders. The association between anorexia nervosa and psychotic disorders is less studied than that with affective disorders (anxiety/depression). The aim of this study is to describe a psychotic symptom (paranoia) in adolescents with Eating Disorders looking at several potential explicative associated factors: eating disorder symptoms, body image concerns, depression and social anxiety. Our hypothesis is that paranoia in AN patients is more explained by the concomitant depression and social anxiety symptoms than core symptoms of the disease (eating disorder symptoms or body image concerns). Methods: this is a retrospective cross sectional study and consecutive, help-seeking adolescents admitted to the Eating Disorder service of the Integrated Pediatric Care Department, Luigi Vanvitelli University Hospital constituted the sample. Data was obtained trough retrospective collection of clinical interviews and self – report questionnaires administered by trained and expert child and adolescent psychiatrists. Results: We obtained data from 92 adolescents with Eating Disorders. Paranoia was dimensionally distributed in the sample (mean: 22,17 SD: 17,7; median 18 IQR: 7/36; range: 0-62). Our regression model explained that paranoia in this population was better explained by depression (coefficient= 0,415 SD: 0,210, p=0,052) and social anxiety symptoms (coefficient= 0,253 SD: 0,060; p<0,001) than eating disorder symptoms (coefficient= 0,092 SD: 0,107; p=0,398) and body image concerns (coefficient= 1,916 SD: 2,079; p=0,359) that did not retain their significance when all our predictive factors entered in the model. Conclusion: This study has some theoretical, clinical and treatment implications. It is important to carrying out screening for the presence of psychotic symptoms in patients with Eating Disorders. These symptoms and associated factors (depression and social anxiety) may complicate the clinical picture of the disease with the need, in certain cases, of psychopharmacological drugs and, among these, anti-psychotics. Finally in the psychotherapy context, paranoid idea may be subject of treatment for patient with EDs.

Download Full-text

Social anxiety in a multiple sclerosis clinic population

Multiple Sclerosis Journal ◽

10.1177/1352458508099143 ◽

2009 ◽

Vol 15 (3) ◽

pp. 393-398 ◽

Cited By ~ 27

Author(s):

K Poder ◽

K Ghatavi ◽

JD Fisk ◽

TL Campbell ◽

S Kisely ◽

...

Keyword(s):

Social Anxiety ◽

Depression Scale ◽

Research Unit ◽

Anxiety Symptoms ◽

Self Report ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Neurological Disability ◽

General Anxiety ◽

Neurologic Disability

Background Little is known about social anxiety in MS. Objective We estimated the prevalence of social anxiety symptoms and their association with demographic and clinical features in a clinic-attending sample of patients with MS. Methods Patients attending the Dalhousie MS Research Unit for regularly scheduled visits completed the Social Phobia Inventory (SPIN), the Hospital Anxiety and Depression Scale (HADS), and the Health Utilities Index (HUI). Neurological disability was determined by ratings on the Expanded Disability Status Scale (EDSS). Results A total of 251 patients completed self-report scales of anxiety and depression symptoms. In all, 245 (98%) provided sufficient data for analysis. In all, 30.6% ( n = 75) had clinically significant social anxiety symptoms as defined by a SPIN threshold score of 19. Half of those with social anxiety had general anxiety (HADSA ≥ 11) and a quarter had depression (HADSD ≥ 11). Severity of social anxiety symptoms was associated with reduced health-related quality of life and not related to neurological disability. Conclusions Social anxiety symptoms are common in persons with MS, contribute to overall morbidity, but are unrelated to the overall severity of neurologic disability. Greater awareness and routine systematic inquiry of social anxiety symptoms is an important component of comprehensive care for persons with MS.

Download Full-text

Psychological distress in adults with congenital heart disease: focus beyond depression

Cardiology in the Young ◽

10.1017/s1047951118002068 ◽

2019 ◽

Vol 29 (2) ◽

pp. 185-189 ◽

Cited By ~ 9

Author(s):

Lacey P. Gleason ◽

Lisa X. Deng ◽

Abigail M. Khan ◽

David Drajpuch ◽

Stephanie Fuller ◽

...

Keyword(s):

Quality Of Life ◽

Congenital Heart Disease ◽

Heart Disease ◽

Congenital Heart ◽

Depression Scale ◽

Anxiety Symptoms ◽

Satisfaction With Life Scale ◽

Anxiety And Depression ◽

Depression Symptoms

AbstractBackgroundAdults with congenital heart disease face psychological challenges although an understanding of depression vs. anxiety symptoms is unclear. We analyzed the prevalence of elevated symptoms of anxiety and depression and explored associations with demographic and medical factors as well as quality of life.MethodsAdults with congenital heart disease enrolled from an outpatient clinic completed the Hospital Anxiety and Depression Scale and two measures of quality of life: the Linear Analogue Scale and the Satisfaction with Life Scale. Medical data were obtained by chart review.ResultsOf 130 patients (median age = 32 years; 55% female), 55 (42%) had elevated anxiety symptoms and 16 (12%) had elevated depression symptoms on subscales of the Hospital Anxiety and Depression Scale. Most patients with elevated depression symptoms also had elevated anxiety symptoms (15/16; 94%). Of 56 patients with at least one elevated subscale, 37 (66%) were not receiving mental health treatment. Compared to patients with 0 or 1 elevated subscales, patients with elevations in both (n=15) were less likely to be studying or working (47% vs. 81%; p=0.016) and reported lower scores on the Linear Analogue Scale (60 vs. 81, p<0.001) and the Satisfaction with Life Scale (14 vs. 28, p<0.001).ConclusionsAmong adults with congenital heart disease, elevated anxiety symptoms are common and typically accompany elevated depressive symptoms. The combination is associated with unemployment and lower quality of life. Improved strategies to provide psychosocial care and support appropriate engagement in employment are required.

Download Full-text

Depressive Psoriasis-Patienten können ein schlechteres Ansprechen auf Etanercept zeigen

Karger Kompass Dermatologie ◽

10.1159/000496272 ◽

2019 ◽

Vol 7 (2) ◽

pp. 75-76

Author(s):

Wiebke Sondermann

Keyword(s):

Clinical Response ◽

Response Rate ◽

Depression Scale ◽

Female Gender ◽

Anxiety Symptoms ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Etanercept Treatment ◽

Depressed Patients ◽

Pasi Score

Background/Aims: This study aimed to investigate the predicting values of depression and anxiety symptoms for clinical response to etanercept treatment in psoriasis patients. Methods: A total of 85 psoriasis patients who received 6 months of etanercept treatment were consecutively enrolled in this prospective cohort study. The Psoriasis Area and Severity Index (PASI) score was evaluated at month 0 (M0), M1, M3, and M6, and the corresponding PASI 75/90 response at each visit was assessed. Also, anxiety and depression symptoms were assessed by the Hospital Anxiety and Depression Scale (HADS) at M0, M1, M3, and M6. Results: Depression symptoms were observed to correlate with female gender (p = 0.004), longer disease duration (p = 0.018), and higher PASI score (p < 0.001), and anxiety symptoms were seen to be associated with female gender (p = 0.017), larger psoriasis-affected body surface area (p = 0.049), and higher PASI score (p = 0.017) in psoriasis patients. After etanercept treatment, HADS-Depression (HADS-D) and HADS-Anxiety (HADS-A) scores were both decreased at M1, M3, and M6 (all p < 0.001) compared with M0. Most importantly, baseline depressed patients presented with a lower PASI 75 response rate at M3 (p = 0.014) and M6 (p = 0.005), and a reduced PASI 90 response rate at M6 (p = 0.045) compared with baseline non-depressed patients. Furthermore, multivariate logistic regression analyses revealed that depression symptoms at baseline were an independent predictive factor for the lower possibility of both PASI 75 response (p = 0.048) and PASI 90 response (p = 0.048) achievements at M6 in psoriasis patients. However, no correlation of baseline anxiety symptoms with PASI 75/90 responses was observed. Conclusion: Depression symptoms at baseline independently predict a worse clinical response to etanercept treatment in psoriasis patients.

Download Full-text

Proportions of anxiety and depression symptoms in adult cleft patients and non-cleft patients with skeletal malocclusions

European Psychiatry ◽

10.1016/j.eurpsy.2017.01.616 ◽

2017 ◽

Vol 41 (S1) ◽

pp. s497-s497

Author(s):

V. Medvedev ◽

Y. Fofanova ◽

V. Frolova ◽

A. Drobyshev

Keyword(s):

Cleft Lip ◽

Cleft Lip And Palate ◽

Anxiety Symptoms ◽

Open Bite ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Class Iii ◽

Anterior Open Bite ◽

Skeletal Class Ii ◽

Reactive Anxiety

IntroductionDiagnosis and treatment of patients with craniofacial anomalies such as cleft lip and palate and skeletal malocclusions present a challenge to public health. Dentofacial abnormalities may be associated with depressive and anxiety disorders and poor quality of life.The aim of this screening study was to evaluate and to compare the rates of anxiety and depression in cleft patients and non-cleft patients with skeletal malocclusions.MethodsThe study used psychometric method-HADS and State Trait Anxiety Inventory were used. The first group consisted of cleft patients, the second group consisted of non-cleft patients with skeletal Class II, Class III and anterior open bite malocclusions; the third group was control.ResultsStudy sample consists of 42 patients (33 females; 24 ± 7.2 years). In the 1st group, anxiety symptoms were detected in 34.7%; depression symptoms - in 17.2% of patients, high rates of reactive anxiety were registered in 35.8%. In the 2nd group, anxiety symptoms were detected in 29.6% of patients; depression symptoms - in 13,1% of patients, high rates of reactive anxiety were registered in 34.2%. In the 3rd group anxiety (18.7%) and depression (8.3%) symptoms and high rates of reactive anxiety (17.7%) were registered significantly less often than in 1st and 2nd groups (P < 0.005, P < 0.001 and P < 0.001 respectively).ConclusionsOur data suggest that cleft-patients and non-cleft patients with skeletal malocclusions have statistically significant higher rates of anxiety and depression than controls and require orthodontic-surgical treatment that should be organized with the assistance of psychiatrist.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Download Full-text

The Relationship between Eating Disorder Symptoms and Treatment Rejection among Young Adult Men in Residential Substance Use Treatment

Substance Abuse Research and Treatment ◽

10.4137/sart.s33396 ◽

2016 ◽

Vol 10 ◽

pp. SART.S33396 ◽

Cited By ~ 6

Author(s):

JoAnna Elmquist ◽

Ryan C. Shorey ◽

Scott E. Anderson ◽

Jeff R. Temple ◽

Gregory L. Stuart

Keyword(s):

Substance Use ◽

Eating Disorder ◽

Young Adult ◽

Mental Health Problems ◽

Hierarchical Regression ◽

Future Research ◽

Depression Symptoms ◽

Negative Consequences ◽

Adult Men ◽

Eating Disorder Symptoms

Research has demonstrated that individuals with substance use disorders (SUDs) and comorbid mental health problems evidence heightened negative consequences, including poorer treatment outcomes, a higher risk for relapse, and mortality compared to individuals with a single disorder. In this study, we focus on the comorbidity between SUDs and eating disorder (ED) symptomatology, as EDs are similarly associated with high rates of relapse, morbidity, and mortality. Of particular importance is research examining treatment rejection among individuals in treatment for SUDs with cooccurring ED symptomatology. This study seeks to add to the literature by examining treatment rejection among young adult men in residential treatment for SUDs ( N = 68) with cooccurring ED symptomatology. Results from hierarchical regression analyses indicated that ED symptoms were significantly associated with treatment rejection after controlling for alcohol and drug use and problems and depression symptoms. Although this is a preliminary study, the results add to a growing body of research examining the comorbidity between SUDs and ED symptomatology. Future research examining this relationship is needed to further elucidate the treatment patterns among individuals with comorbid ED symptoms and substance use diagnoses.

Download Full-text

Anxiety symptoms and suicidal feelings in a population sample of 70-year-olds without dementia

International Psychogeriatrics ◽

10.1017/s1041610212000993 ◽

2012 ◽

Vol 24 (11) ◽

pp. 1865-1871 ◽

Cited By ~ 7

Author(s):

Mattias Jonson ◽

Ingmar Skoog ◽

Thomas Marlow ◽

Madeleine Mellqvist Fässberg ◽

Margda Waern

Keyword(s):

Suicidal Behavior ◽

Anxiety Symptom ◽

Rating Scale ◽

Population Sample ◽

Symptom Burden ◽

Late Life ◽

Anxiety Symptoms ◽

Psychiatric Nurses ◽

Depression Symptoms

ABSTRACTBackground: The role of anxiety in late-life suicidal behavior has received relatively little attention. The aim was to explore the association between anxiety symptoms and suicidal feelings in a population sample of 70-year-olds without dementia, and to test whether associations would be independent of depression.Methods: Face-to-face interviews (N = 560) were carried out by psychiatric nurses and past month symptoms were rated with the Comprehensive Psychopathological Rating Scale (CPRS). The Brief Scale for Anxiety (BSA) was derived from the CPRS to quantify anxiety symptom burden. Past month suicidal feelings were evaluated with the Paykel questions.Results: Anxiety symptom burden was associated with suicidal feelings and the association remained after adjusting for major depression. One individual BSA item (Inner tension) was independently associated with suicidal feelings in a multivariate regression model. The association did not remain, however, in a final model in which depression symptoms replaced depression diagnosis.Conclusions: Results from this population study suggest an association between anxiety and suicidal feelings in older adults. The role of anxiety and depression symptoms needs further clarification in the study of suicidal behavior in late life.

Download Full-text